Biopharm, one of Mediterrania Capital’s portfolio companies, enters the Algiers Stock

Mediterrania Capital Partners, the regional Private Equity firm focusing on growth investments for companies in North African and Sub-Saharan countries, announces that Biopharm, one of Mediterrania Capital II’s portfolio companies, has entered the Algiers Stock Exchange.

On 7th April, Biopharm listed its securities on the Algiers Stock Exchange’s secondary market by offering 20% of its shares. It is the third private company entering this market.

Biopharm, which was founded in 1991, is led by the Algerian entrepreneur Mr. Abdelmajid Kerrar. The company imports, manufactures and distributes pharmaceutical products in Algeria, a country with growing demand and expenditure for health-related products as household incomes increase. With nearly 1,800 employees and revenues of 51 billion DA, Biopharm leads the pharmaceutical market in Algeria. As well as providing access to its products in remote markets by establishing warehouses in rural regions of Algeria, Biopharm also exports a wide range of pharmaceutical products to Mali, Niger, Mauritania, Libya, and Tunisia.

Since 2013, Biopharm is 49% owned by a financial consortium that includes Mediterrania Capital Partners.

Since the arrival of the consortium of investors, Biopharm’s R&D laboratory, the largest in Algeria, has tripled its personnel and obtained the coveted French ANSM quality accreditation. On the other hand, in line with the company’s strong focus on ESG policies, the company has implemented best-in-class water treatment technologies and a robust recycling policy. Furthermore, during this time, Biopharm has created a unit that shares and promotes medical information to ensure Algerian medical staff are up-to-date with the latest trends and solutions.

About Mediterrania Capital Partners

Mediterrania Capital Partners (www.mcapitalp.com) is a dedicated private equity firm focusing on African and mainly North African growth investments in SMEs and mid-cap companies. The company started its operations in 2008 under “Fons Mediterrania Capital” and since 2013 is an independent General Partner Structure.

Mediterrania Capital Partners is a regulated financial investment manager licensed by the Malta Financial Services Authority (MFSA). Mediterrania Capital II is also an MFSA regulated Private Equity Fund.

For more information, please contact us

Website: www.mcapitalp.com
YouTube channel: www.youtube.com/channel/UCmBxa-EDilIWakYJr1_J6SQ
LinkedIn: www.linkedin.com/company/mediterrania-capital-partners